LSTA · Lisata Therapeutics, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and existing capital resources, management has concluded that there is substantial doubt regarding our ability to continue as a going concern for a period of twelve months from the date of issuance of the accompanying consolidated financial statements.”View the 10-Q filed Aug 6, 2026
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Sep 15, 2022; bars on opposite sides are not compared.
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LSTA
this stock
Lisata Therapeutics, Inc.
|
$17.12M | +2.2% | +56.9% | — | 1.0% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.08B | +14.9% | +46.2% | 30.4 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.15B | +4.6% | +20.8% | 20.0 | 2.3% |
|
ARGX
Argenx SE
|
$62.33B | +19.2% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$58.10B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Sep 15, 2022; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LSTA | +21.0% | +57.0% | -62.1% | +27.5% | +2.2% |
| SPY | +0.1% | -1.1% | +15.3% | -0.6% | +11.8% |
| vs SPY | +20.9% | +58.1% | -77.4% | +28.1% | -9.7% |